PRF1 and cancer: Antigens derived from tumor tissues can activate CD8+ T cells to produce anti-cancer responses, improving pore formation in target tumor cell membranes and subsequent target-cell killing by secreting cathepsin C, perforin, and granulysin to fusion target cell membranes.